Serum sperm antibodies are not elevated after mumps orchitis

Area of Science:

• Immunology
• Reproductive Medicine
• Infectious Diseases

Background:

• Mumps orchitis, a complication of mumps infection, can potentially affect male reproductive health.
• The immune response, specifically the development of sperm antibodies, following mumps orchitis is not fully understood.

Purpose of the Study:

• To evaluate the presence and levels of serum sperm antibodies in patients who have experienced mumps orchitis.
• To determine if mumps orchitis leads to a significant increase in humoral immunity against spermatozoa.

Main Methods:

• A controlled descriptive study was conducted in an academic research setting.
• Serum samples were collected from 74 mumps orchitis patients at various intervals post-onset (1-7 days, 31-60 days, 61-431 days).
• Sperm antibody levels were assessed using Kibrick's gelatin agglutination test, Friberg's tray agglutination test, Isojima's sperm immobilization test, and ELISA.

Main Results:

• The Friberg method detected relevant sperm antibodies in 10.5% of patients at both early (1-7 days) and late (61-431 days) stages.
• The Isojima test showed a non-significant trend towards higher antibody incidence in the later sampling group (31.6% vs. 10.5%).
• Kibrick and ELISA methods did not detect positive results; incidences were comparable to negative controls and lower than positive controls for infertility.

Conclusions:

• Mumps orchitis does not appear to induce a significant or lasting enhancement of humoral immunity directed at spermatozoa.
• The observed sperm antibody levels were generally low and not significantly different from healthy controls, suggesting limited immunological impact on sperm.